Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0000979 | HP:0000979 | Purpura | 0 | ACP5 CL E G H | 54 | 124 | OMIM:607944 | Spondyloenchondrodysplasia with immune dysregulation | . | | | 16 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ADA2 CL E G H | 51816 | 1839 | OMIM:615688 | Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome | | | | 22 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | AIP CL E G H | 9049 | 358 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 95 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | APOE CL E G H | 348 | 613 | ORPHA:158029 | Sea-blue histiocytosis | | | | 39 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ARL6IP6 CL E G H | 151188 | 24048 | ORPHA:1556 | Cutis marmorata telangiectatica congenita | HP:0040283 - Occasional | | | 1 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ARVCF CL E G H | 421 | 728 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 1 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | BCOR CL E G H | 54880 | 20893 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 101 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | C2 CL E G H | 717 | 1248 | OMIM:217000 | Complement component 2 deficiency | . | | | 23 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | C4A CL E G H | 720 | 1323 | OMIM:614380 | Complement component 4A deficiency | . | | | 1 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CALR CL E G H | 811 | 1455 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 1 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CALR CL E G H | 811 | 1455 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 1 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CASP10 CL E G H | 843 | 1500 | OMIM:603909 | Autoimmune lymphoproliferative syndrome, type IIA | | | | 87 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CD109 CL E G H | 135228 | 21685 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CD19 CL E G H | 930 | 1633 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 38 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CD81 CL E G H | 975 | 1701 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 1 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CD81 CL E G H | 975 | 1701 | OMIM:613496 | Immunodeficiency, common variable, 6 | | | | 1 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CFH CL E G H | 3075 | 4883 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | 86 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CFHR1 CL E G H | 3078 | 4888 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CFHR3 CL E G H | 10878 | 16980 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CHST14 CL E G H | 113189 | 24464 | OMIM:601776 | Ehlers-Danlos syndrome, musculocontractural type 1 | | | | 27 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CLCN7 CL E G H | 1186 | 2025 | OMIM:611490 | Osteopetrosis, autosomal recessive 4 | | | | 102 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 373 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | COL3A1 CL E G H | 1281 | 2201 | OMIM:130050 | Ehlers-Danlos syndrome, Vascular type | | | | 749 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | COL5A1 CL E G H | 1289 | 2209 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 660 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | COL5A2 CL E G H | 1290 | 2210 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 325 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | COMT CL E G H | 1312 | 2228 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 6 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CR2 CL E G H | 1380 | 2336 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 10 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | 10 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ETHE1 CL E G H | 23474 | 23287 | OMIM:602473 | Encephalopathy, ethylmalonic | | | | 42 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ETHE1 CL E G H | 23474 | 23287 | ORPHA:51188 | Ethylmalonic encephalopathy | | | | 42 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ETV6 CL E G H | 2120 | 3495 | OMIM:616216 | Thrombocytopenia 5 | | | | 13 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | F13A1 CL E G H | 2162 | 3531 | ORPHA:331 | Congenital factor XIII deficiency | | | | 60 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | F13A1 CL E G H | 2162 | 3531 | OMIM:613225 | Factor XIII, A subunit, deficiency of | | | | 60 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | F13B CL E G H | 2165 | 3534 | ORPHA:331 | Congenital factor XIII deficiency | | | | 32 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | F13B CL E G H | 2165 | 3534 | OMIM:613235 | Factor XIIIB deficiency | | | | 32 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | F2 CL E G H | 2147 | 3535 | OMIM:613679 | Congenital prothrombin deficiency | | | | 44 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | FCGR2C CL E G H | 9103 | 15626 | ORPHA:3002 | Immune thrombocytopenia | HP:0040282 - Frequent | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | FERMT3 CL E G H | 83706 | 23151 | OMIM:612840 | Leukocyte adhesion deficiency, type III | | | | 23 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | FIP1L1 CL E G H | 81608 | 19124 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 4 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | FYB1 CL E G H | 2533 | 4036 | OMIM:273900 | THROMBOCYTOPENIA 3; THC3 | | | | 4 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GATA1 CL E G H | 2623 | 4170 | OMIM:314050 | Thrombocytopenia with beta-thalassemia, X-linked | | | | 29 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GATA1 CL E G H | 2623 | 4170 | OMIM:300367 | Thrombocytopenia, X-linked, with or without dyserythropoietic anemia | | | | 29 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GBA1 CL E G H | 2629 | 4177 | OMIM:608013 | Gaucher disease, perinatal lethal | . | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GBA1 CL E G H | 2629 | 4177 | ORPHA:2072 | Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome | | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GFI1B CL E G H | 8328 | 4238 | OMIM:187900 | Bleeding disorder, platelet-type, 17 | | | | 3 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GGCX CL E G H | 2677 | 4247 | OMIM:277450 | VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1 | | | | 129 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GIMAP5 CL E G H | 55340 | 18005 | OMIM:619463 | PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2 | | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GNA11 CL E G H | 2767 | 4379 | ORPHA:1556 | Cutis marmorata telangiectatica congenita | HP:0040283 - Occasional | | | 16 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GNA14 CL E G H | 9630 | 4382 | ORPHA:1063 | Tufted angioma | HP:0040283 - Occasional | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GP1BA CL E G H | 2811 | 4439 | ORPHA:274 | Bernard-Soulier syndrome | | | | 23 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GP1BA CL E G H | 2811 | 4439 | OMIM:153670 | Bernard-Soulier syndrome, type A2, autosomal dominant | | | | 23 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GP1BA CL E G H | 2811 | 4439 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 23 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GP1BA CL E G H | 2811 | 4439 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 23 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GP1BB CL E G H | 2812 | 4440 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 8 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GP1BB CL E G H | 2812 | 4440 | ORPHA:274 | Bernard-Soulier syndrome | | | | 8 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GP1BB CL E G H | 2812 | 4440 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 8 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GP1BB CL E G H | 2812 | 4440 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 8 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GP6 CL E G H | 51206 | 14388 | OMIM:614201 | Bleeding disorder, platelet-type, 11 | | | | 24 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GP9 CL E G H | 2815 | 4444 | ORPHA:274 | Bernard-Soulier syndrome | | | | 21 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | GP9 CL E G H | 2815 | 4444 | OMIM:231200 | BERNARD-SOULIER SYNDROME; BSS | | | | 21 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | HIRA CL E G H | 7290 | 4916 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 3 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | HLA-DPA1 CL E G H | 3113 | 4938 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | HLA-DPB1 CL E G H | 3115 | 4940 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | 1 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | HOXA11 CL E G H | 3207 | 5101 | OMIM:605432 | Radioulnar synostosis with amegakaryocytic thrombocytopenia | . | | | 3 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | HPS1 CL E G H | 3257 | 5163 | OMIM:203300 | Hermansky-Pudlak syndrome 1 | | | | 121 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | HPS6 CL E G H | 79803 | 18817 | OMIM:614075 | Hermansky-Pudlak syndrome 6 | | | | 45 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ICOS CL E G H | 29851 | 5351 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 32 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | IFNG CL E G H | 3458 | 5438 | ORPHA:88 | Idiopathic aplastic anemia | | | | 23 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 4 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 4 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ITGA2 CL E G H | 3673 | 6137 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 119 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ITGA2B CL E G H | 3674 | 6138 | OMIM:187800 | Bleeding disorder, platelet-type, 16 | | | | 69 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 69 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ITGA2B CL E G H | 3674 | 6138 | OMIM:273800 | Glanzmann thrombasthenia | . | | | 69 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:849 | Glanzmann thrombasthenia | HP:0040283 - Occasional | | | 69 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 80 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:849 | Glanzmann thrombasthenia | HP:0040283 - Occasional | | | 80 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | JAK2 CL E G H | 3717 | 6192 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 57 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | JAK2 CL E G H | 3717 | 6192 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 57 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | JMJD1C CL E G H | 221037 | 12313 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 2 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | LCP2 CL E G H | 3937 | 6529 | OMIM:619374 | IMMUNODEFICIENCY 81; IMD81 | | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | MPL CL E G H | 4352 | 7217 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 97 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | MPL CL E G H | 4352 | 7217 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 97 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | MS4A1 CL E G H | 931 | 7315 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 1 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | MVK CL E G H | 4598 | 7530 | ORPHA:343 | Hyperimmunoglobulinemia D with periodic fever | HP:0040283 - Occasional | | | 150 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | MYD88 CL E G H | 4615 | 7562 | ORPHA:33226 | Waldenström macroglobulinemia | HP:0040283 - Occasional | | | 9 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | NABP1 CL E G H | 64859 | 26232 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | NEU1 CL E G H | 4758 | 7758 | ORPHA:93400 | Congenital sialidosis type 2 | | | | 43 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | NFKB1 CL E G H | 4790 | 7794 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 7 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 11 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | NLRP3 CL E G H | 114548 | 16400 | ORPHA:1451 | CINCA syndrome | HP:0040283 - Occasional | | | 217 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | NPM1 CL E G H | 4869 | 7910 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 12 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | NUMA1 CL E G H | 4926 | 8059 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | OCLN CL E G H | 100506658 | 8104 | OMIM:251290 | Band-Like calcification with simplified gyration and polymicrogyria | | | | 23 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ORAI1 CL E G H | 84876 | 25896 | ORPHA:3204 | Stormorken-Sjaastad-Langslet syndrome | HP:0040281 - Very frequent | | | 19 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | P2RY12 CL E G H | 64805 | 18124 | OMIM:609821 | Bleeding disorder, platelet-type, 8 | | | | 5 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | PEPD CL E G H | 5184 | 8840 | OMIM:170100 | Prolidase deficiency | | | | 66 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | PML CL E G H | 5371 | 9113 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 3 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 58 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | PRF1 CL E G H | 5551 | 9360 | ORPHA:88 | Idiopathic aplastic anemia | | | | 58 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 134 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | PRKCD CL E G H | 5580 | 9399 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 10 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | PROC CL E G H | 5624 | 9451 | ORPHA:745 | Severe hereditary thrombophilia due to congenital protein C deficiency | HP:0040282 - Frequent | | | 65 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | PROC CL E G H | 5624 | 9451 | OMIM:612304 | Thrombophilia due to protein C deficiency, autosomal recessive | . | | | 65 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | PROS1 CL E G H | 5627 | 9456 | ORPHA:743 | Severe hereditary thrombophilia due to congenital protein S deficiency | HP:0040281 - Very frequent | | | 75 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | PROS1 CL E G H | 5627 | 9456 | OMIM:614514 | Thrombophilia due to protein S deficiency, autosomal recessive | . | | | 75 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | PROS1 CL E G H | 5627 | 9456 | OMIM:612336 | Thrombophilia, hereditary, due to protein S deficiency, autosomal | . | | | 75 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | PRTN3 CL E G H | 5657 | 9495 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | PTPN22 CL E G H | 26191 | 9652 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | 3 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | RAB27A CL E G H | 5873 | 9766 | ORPHA:79477 | Griscelli syndrome type 2 | | | | 67 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | RARA CL E G H | 5914 | 9864 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 2 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | RREB1 CL E G H | 6239 | 10449 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | SAMD9 CL E G H | 54809 | 1348 | OMIM:617053 | Mirage syndrome | | | | 8 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | SBDS CL E G H | 51119 | 19440 | ORPHA:88 | Idiopathic aplastic anemia | | | | 26 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | SEC24C CL E G H | 9632 | 10705 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | SH2B3 CL E G H | 10019 | 29605 | OMIM:254450 | Myelofibrosismyelofibrosis with myeloid metaplasia, included | | | | 4 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | STAT3 CL E G H | 6774 | 11364 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 110 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | STAT5B CL E G H | 6777 | 11367 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 12 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | STIM1 CL E G H | 6786 | 11386 | ORPHA:3204 | Stormorken-Sjaastad-Langslet syndrome | HP:0040281 - Very frequent | | | 31 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 85 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 70 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | TBL1XR1 CL E G H | 79718 | 29529 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 22 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | TBX1 CL E G H | 6899 | 11592 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | 32 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | TBXA2R CL E G H | 6915 | 11608 | OMIM:614009 | BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13 | | | | 10 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | TERC CL E G H | 7012 | 11727 | ORPHA:88 | Idiopathic aplastic anemia | | | | 48 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | TERT CL E G H | 7015 | 11730 | ORPHA:88 | Idiopathic aplastic anemia | | | | 238 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | TET2 CL E G H | 54790 | 25941 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 3 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | TFR2 CL E G H | 7036 | 11762 | OMIM:604250 | Hemochromatosis, type 3 | . | | | 67 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | TNFRSF13B CL E G H | 23495 | 18153 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 32 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | TNFRSF13C CL E G H | 115650 | 17755 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 12 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | TNFSF12 CL E G H | 8742 | 11927 | ORPHA:1572 | Common variable immunodeficiency | HP:0040282 - Frequent | | | 1 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | . | | | 56 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | UFD1 CL E G H | 7353 | 12520 | ORPHA:567 | 22q11.2 deletion syndrome | HP:0040283 - Occasional | | | | | |
HP:0000979 | HP:0000979 | Purpura | 0 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 116 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | USP18 CL E G H | 11274 | 12616 | OMIM:617397 | Pseudo-Torch syndrome 2 | | | | 2 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | USP8 CL E G H | 9101 | 12631 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 7 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | WAS CL E G H | 7454 | 12731 | OMIM:313900 | Thrombocytopenia 1 | | | | 65 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | WAS CL E G H | 7454 | 12731 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040282 - Frequent | | | 65 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | WAS CL E G H | 7454 | 12731 | OMIM:301000 | Wiskott-Aldrich syndrome | . | | | 65 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | WIPF1 CL E G H | 7456 | 12736 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040282 - Frequent | | | 6 | | |
HP:0000979 | HP:0000979 | Purpura | 0 | ZBTB16 CL E G H | 7704 | 12930 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 1 | | |
HP:0000979 | HP:0031363 | Palpable purpura | 1 | CL E G H | | | | | | | | | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | AIP CL E G H | 9049 | 358 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | | | | 95 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | APOE CL E G H | 348 | 613 | ORPHA:158029 | Sea-blue histiocytosis | | | | 39 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | BCOR CL E G H | 54880 | 20893 | ORPHA:520 | Acute promyelocytic leukemia | | | | 101 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | CALR CL E G H | 811 | 1455 | ORPHA:824 | Primary myelofibrosis | | | | 1 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | CASP10 CL E G H | 843 | 1500 | OMIM:603909 | Autoimmune lymphoproliferative syndrome, type IIA | | | | 87 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | CD109 CL E G H | 135228 | 21685 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | CHST14 CL E G H | 113189 | 24464 | OMIM:601776 | Ehlers-Danlos syndrome, musculocontractural type 1 | | | | 27 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | CLCN7 CL E G H | 1186 | 2025 | OMIM:611490 | Osteopetrosis, autosomal recessive 4 | | | | 102 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 373 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | COL3A1 CL E G H | 1281 | 2201 | OMIM:130050 | Ehlers-Danlos syndrome, Vascular type | | | | 749 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | COL5A1 CL E G H | 1289 | 2209 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 660 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | COL5A2 CL E G H | 1290 | 2210 | ORPHA:287 | Classical Ehlers-Danlos syndrome | | | | 325 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | ETHE1 CL E G H | 23474 | 23287 | OMIM:602473 | Encephalopathy, ethylmalonic | | | | 42 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | ETHE1 CL E G H | 23474 | 23287 | ORPHA:51188 | Ethylmalonic encephalopathy | | | | 42 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | ETV6 CL E G H | 2120 | 3495 | OMIM:616216 | Thrombocytopenia 5 | | | | 13 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | F13A1 CL E G H | 2162 | 3531 | ORPHA:331 | Congenital factor XIII deficiency | | | | 60 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | F13A1 CL E G H | 2162 | 3531 | OMIM:613225 | Factor XIII, A subunit, deficiency of | | | | 60 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | F13B CL E G H | 2165 | 3534 | ORPHA:331 | Congenital factor XIII deficiency | | | | 32 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | F13B CL E G H | 2165 | 3534 | OMIM:613235 | Factor XIIIB deficiency | | | | 32 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | F2 CL E G H | 2147 | 3535 | OMIM:613679 | Congenital prothrombin deficiency | | | | 44 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | FCGR2C CL E G H | 9103 | 15626 | ORPHA:3002 | Immune thrombocytopenia | | | | | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | FERMT3 CL E G H | 83706 | 23151 | OMIM:612840 | Leukocyte adhesion deficiency, type III | | | | 23 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | FIP1L1 CL E G H | 81608 | 19124 | ORPHA:520 | Acute promyelocytic leukemia | | | | 4 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | FYB1 CL E G H | 2533 | 4036 | OMIM:273900 | THROMBOCYTOPENIA 3; THC3 | | | | 4 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GATA1 CL E G H | 2623 | 4170 | OMIM:314050 | Thrombocytopenia with beta-thalassemia, X-linked | | | | 29 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GATA1 CL E G H | 2623 | 4170 | OMIM:300367 | Thrombocytopenia, X-linked, with or without dyserythropoietic anemia | | | | 29 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GBA1 CL E G H | 2629 | 4177 | OMIM:608013 | Gaucher disease, perinatal lethal | | | | | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GBA1 CL E G H | 2629 | 4177 | ORPHA:2072 | Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome | | | | | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GFI1B CL E G H | 8328 | 4238 | OMIM:187900 | Bleeding disorder, platelet-type, 17 | | | | 3 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GGCX CL E G H | 2677 | 4247 | OMIM:277450 | VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1 | | | | 129 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GIMAP5 CL E G H | 55340 | 18005 | OMIM:619463 | PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2 | | | | | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GNA14 CL E G H | 9630 | 4382 | ORPHA:1063 | Tufted angioma | | | | | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GP1BA CL E G H | 2811 | 4439 | ORPHA:274 | Bernard-Soulier syndrome | | | | 23 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GP1BA CL E G H | 2811 | 4439 | OMIM:153670 | Bernard-Soulier syndrome, type A2, autosomal dominant | | | | 23 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GP1BA CL E G H | 2811 | 4439 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 23 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GP1BB CL E G H | 2812 | 4440 | ORPHA:274 | Bernard-Soulier syndrome | | | | 8 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GP1BB CL E G H | 2812 | 4440 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 8 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GP6 CL E G H | 51206 | 14388 | OMIM:614201 | Bleeding disorder, platelet-type, 11 | | | | 24 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | GP9 CL E G H | 2815 | 4444 | ORPHA:274 | Bernard-Soulier syndrome | | | | 21 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | HOXA11 CL E G H | 3207 | 5101 | OMIM:605432 | Radioulnar synostosis with amegakaryocytic thrombocytopenia | | | | 3 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | HPS1 CL E G H | 3257 | 5163 | OMIM:203300 | Hermansky-Pudlak syndrome 1 | | | | 121 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | HPS6 CL E G H | 79803 | 18817 | OMIM:614075 | Hermansky-Pudlak syndrome 6 | | | | 45 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | IFNG CL E G H | 3458 | 5438 | ORPHA:88 | Idiopathic aplastic anemia | | | | 23 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:520 | Acute promyelocytic leukemia | | | | 4 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | ITGA2 CL E G H | 3673 | 6137 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 119 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | ITGA2B CL E G H | 3674 | 6138 | OMIM:187800 | Bleeding disorder, platelet-type, 16 | | | | 69 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 69 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:849 | Glanzmann thrombasthenia | | | | 69 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | ITGA2B CL E G H | 3674 | 6138 | OMIM:273800 | Glanzmann thrombasthenia | | | | 69 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | | | | 80 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:849 | Glanzmann thrombasthenia | | | | 80 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | JAK2 CL E G H | 3717 | 6192 | ORPHA:824 | Primary myelofibrosis | | | | 57 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | LCP2 CL E G H | 3937 | 6529 | OMIM:619374 | IMMUNODEFICIENCY 81; IMD81 | | | | | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | MPL CL E G H | 4352 | 7217 | ORPHA:824 | Primary myelofibrosis | | | | 97 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | NABP1 CL E G H | 64859 | 26232 | ORPHA:520 | Acute promyelocytic leukemia | | | | | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | NEU1 CL E G H | 4758 | 7758 | ORPHA:93400 | Congenital sialidosis type 2 | | | | 43 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | NPM1 CL E G H | 4869 | 7910 | ORPHA:520 | Acute promyelocytic leukemia | | | | 12 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | NUMA1 CL E G H | 4926 | 8059 | ORPHA:520 | Acute promyelocytic leukemia | | | | | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | OCLN CL E G H | 100506658 | 8104 | OMIM:251290 | Band-Like calcification with simplified gyration and polymicrogyria | | | | 23 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | P2RY12 CL E G H | 64805 | 18124 | OMIM:609821 | Bleeding disorder, platelet-type, 8 | | | | 5 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | PEPD CL E G H | 5184 | 8840 | OMIM:170100 | Prolidase deficiency | | | | 66 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | PML CL E G H | 5371 | 9113 | ORPHA:520 | Acute promyelocytic leukemia | | | | 3 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 58 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | PRF1 CL E G H | 5551 | 9360 | ORPHA:88 | Idiopathic aplastic anemia | | | | 58 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:520 | Acute promyelocytic leukemia | | | | 134 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | RAB27A CL E G H | 5873 | 9766 | ORPHA:79477 | Griscelli syndrome type 2 | | | | 67 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | RARA CL E G H | 5914 | 9864 | ORPHA:520 | Acute promyelocytic leukemia | | | | 2 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | SAMD9 CL E G H | 54809 | 1348 | OMIM:617053 | Mirage syndrome | | | | 8 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | SBDS CL E G H | 51119 | 19440 | ORPHA:88 | Idiopathic aplastic anemia | | | | 26 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | STAT3 CL E G H | 6774 | 11364 | ORPHA:520 | Acute promyelocytic leukemia | | | | 110 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | STAT5B CL E G H | 6777 | 11367 | ORPHA:520 | Acute promyelocytic leukemia | | | | 12 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 85 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 70 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | TBL1XR1 CL E G H | 79718 | 29529 | ORPHA:520 | Acute promyelocytic leukemia | | | | 22 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | TBXA2R CL E G H | 6915 | 11608 | OMIM:614009 | BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13 | | | | 10 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | TERC CL E G H | 7012 | 11727 | ORPHA:88 | Idiopathic aplastic anemia | | | | 48 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | TERT CL E G H | 7015 | 11730 | ORPHA:88 | Idiopathic aplastic anemia | | | | 238 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | TET2 CL E G H | 54790 | 25941 | ORPHA:824 | Primary myelofibrosis | | | | 3 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | | | | 56 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 116 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | USP18 CL E G H | 11274 | 12616 | OMIM:617397 | Pseudo-Torch syndrome 2 | | | | 2 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | USP8 CL E G H | 9101 | 12631 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | | | | 7 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | WAS CL E G H | 7454 | 12731 | OMIM:313900 | Thrombocytopenia 1 | | | | 65 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | WAS CL E G H | 7454 | 12731 | OMIM:301000 | Wiskott-Aldrich syndrome | | | | 65 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | WAS CL E G H | 7454 | 12731 | ORPHA:906 | Wiskott-Aldrich syndrome | | | | 65 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | WIPF1 CL E G H | 7456 | 12736 | ORPHA:906 | Wiskott-Aldrich syndrome | | | | 6 | | |
HP:0000979 | HP:0031365 | Macular purpura | 1 | ZBTB16 CL E G H | 7704 | 12930 | ORPHA:520 | Acute promyelocytic leukemia | | | | 1 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | AIP CL E G H | 9049 | 358 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 95 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | APOE CL E G H | 348 | 613 | ORPHA:158029 | Sea-blue histiocytosis | HP:0040281 - Very frequent | | | 39 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | BCOR CL E G H | 54880 | 20893 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 101 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | BCOR CL E G H | 54880 | 20893 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 101 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | CALR CL E G H | 811 | 1455 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 1 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | CALR CL E G H | 811 | 1455 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 1 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | CASP10 CL E G H | 843 | 1500 | OMIM:603909 | Autoimmune lymphoproliferative syndrome, type IIA | | | | 87 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | CD109 CL E G H | 135228 | 21685 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | CD109 CL E G H | 135228 | 21685 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040283 - Occasional | | | | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | CHST14 CL E G H | 113189 | 24464 | OMIM:601776 | Ehlers-Danlos syndrome, musculocontractural type 1 | . | | | 27 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | CLCN7 CL E G H | 1186 | 2025 | OMIM:611490 | Osteopetrosis, autosomal recessive 4 | . | | | 102 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | COL1A1 CL E G H | 1277 | 2197 | ORPHA:287 | Classical Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 373 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | COL3A1 CL E G H | 1281 | 2201 | OMIM:130050 | Ehlers-Danlos syndrome, Vascular type | | | | 749 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | COL5A1 CL E G H | 1289 | 2209 | ORPHA:287 | Classical Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 660 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | COL5A2 CL E G H | 1290 | 2210 | ORPHA:287 | Classical Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 325 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | ETHE1 CL E G H | 23474 | 23287 | OMIM:602473 | Encephalopathy, ethylmalonic | . | | | 42 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | ETHE1 CL E G H | 23474 | 23287 | ORPHA:51188 | Ethylmalonic encephalopathy | HP:0040282 - Frequent | | | 42 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | ETV6 CL E G H | 2120 | 3495 | OMIM:616216 | Thrombocytopenia 5 | . | | | 13 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | F13A1 CL E G H | 2162 | 3531 | ORPHA:331 | Congenital factor XIII deficiency | HP:0040283 - Occasional | | | 60 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | F13A1 CL E G H | 2162 | 3531 | OMIM:613225 | Factor XIII, A subunit, deficiency of | . | | | 60 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | F13B CL E G H | 2165 | 3534 | ORPHA:331 | Congenital factor XIII deficiency | HP:0040283 - Occasional | | | 32 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | F13B CL E G H | 2165 | 3534 | OMIM:613235 | Factor XIIIB deficiency | . | | | 32 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | F2 CL E G H | 2147 | 3535 | OMIM:613679 | Congenital prothrombin deficiency | . | | | 44 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | FCGR2C CL E G H | 9103 | 15626 | ORPHA:3002 | Immune thrombocytopenia | HP:0040282 - Frequent | | | | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | FERMT3 CL E G H | 83706 | 23151 | OMIM:612840 | Leukocyte adhesion deficiency, type III | . | | | 23 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | FIP1L1 CL E G H | 81608 | 19124 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 4 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | FIP1L1 CL E G H | 81608 | 19124 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 4 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | FYB1 CL E G H | 2533 | 4036 | OMIM:273900 | THROMBOCYTOPENIA 3; THC3 | | | | 4 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | GATA1 CL E G H | 2623 | 4170 | OMIM:314050 | Thrombocytopenia with beta-thalassemia, X-linked | . | | | 29 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | GATA1 CL E G H | 2623 | 4170 | OMIM:300367 | Thrombocytopenia, X-linked, with or without dyserythropoietic anemia | . | | | 29 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | GBA1 CL E G H | 2629 | 4177 | OMIM:608013 | Gaucher disease, perinatal lethal | . | | | | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | GBA1 CL E G H | 2629 | 4177 | ORPHA:2072 | Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome | HP:0040284 - Very rare | | | | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | GFI1B CL E G H | 8328 | 4238 | OMIM:187900 | Bleeding disorder, platelet-type, 17 | . | | | 3 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | GFI1B CL E G H | 8328 | 4238 | OMIM:187900 | Bleeding disorder, platelet-type, 17 | . | | | 3 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | GGCX CL E G H | 2677 | 4247 | OMIM:277450 | VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1 | . | | | 129 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | GIMAP5 CL E G H | 55340 | 18005 | OMIM:619463 | PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2 | | | | | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | GIMAP5 CL E G H | 55340 | 18005 | OMIM:619463 | PORTAL HYPERTENSION, NONCIRRHOTIC, 2; NCPH2 | | | | | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | GNA14 CL E G H | 9630 | 4382 | ORPHA:1063 | Tufted angioma | HP:0040283 - Occasional | | | | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | GP1BA CL E G H | 2811 | 4439 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040282 - Frequent | | | 23 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | GP1BA CL E G H | 2811 | 4439 | OMIM:153670 | Bernard-Soulier syndrome, type A2, autosomal dominant | . | | | 23 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | GP1BA CL E G H | 2811 | 4439 | OMIM:153670 | Bernard-Soulier syndrome, type A2, autosomal dominant | . | | | 23 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | GP1BA CL E G H | 2811 | 4439 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 23 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | GP1BA CL E G H | 2811 | 4439 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040283 - Occasional | | | 23 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | GP1BB CL E G H | 2812 | 4440 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040282 - Frequent | | | 8 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | GP1BB CL E G H | 2812 | 4440 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040283 - Occasional | | | 8 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | GP1BB CL E G H | 2812 | 4440 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 8 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | GP6 CL E G H | 51206 | 14388 | OMIM:614201 | Bleeding disorder, platelet-type, 11 | . | | | 24 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | GP9 CL E G H | 2815 | 4444 | ORPHA:274 | Bernard-Soulier syndrome | HP:0040282 - Frequent | | | 21 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | HOXA11 CL E G H | 3207 | 5101 | OMIM:605432 | Radioulnar synostosis with amegakaryocytic thrombocytopenia | . | | | 3 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | HPS1 CL E G H | 3257 | 5163 | OMIM:203300 | Hermansky-Pudlak syndrome 1 | | | | 121 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | HPS6 CL E G H | 79803 | 18817 | OMIM:614075 | Hermansky-Pudlak syndrome 6 | | | | 45 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | IFNG CL E G H | 3458 | 5438 | ORPHA:88 | Idiopathic aplastic anemia | HP:0040283 - Occasional | | | 23 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 4 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 4 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | ITGA2 CL E G H | 3673 | 6137 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040283 - Occasional | | | 119 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | ITGA2 CL E G H | 3673 | 6137 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 119 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | ITGA2B CL E G H | 3674 | 6138 | OMIM:187800 | Bleeding disorder, platelet-type, 16 | . | | | 69 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040283 - Occasional | | | 69 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 69 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | ITGA2B CL E G H | 3674 | 6138 | ORPHA:849 | Glanzmann thrombasthenia | HP:0040283 - Occasional | | | 69 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | ITGA2B CL E G H | 3674 | 6138 | OMIM:273800 | Glanzmann thrombasthenia | | | | 69 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040283 - Occasional | | | 80 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:853 | Fetal and neonatal alloimmune thrombocytopenia | HP:0040282 - Frequent | | | 80 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | ITGB3 CL E G H | 3690 | 6156 | ORPHA:849 | Glanzmann thrombasthenia | HP:0040283 - Occasional | | | 80 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | JAK2 CL E G H | 3717 | 6192 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 57 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | JAK2 CL E G H | 3717 | 6192 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 57 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | LCP2 CL E G H | 3937 | 6529 | OMIM:619374 | IMMUNODEFICIENCY 81; IMD81 | | | | | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | MPL CL E G H | 4352 | 7217 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 97 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | MPL CL E G H | 4352 | 7217 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 97 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | NABP1 CL E G H | 64859 | 26232 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | NABP1 CL E G H | 64859 | 26232 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | NEU1 CL E G H | 4758 | 7758 | ORPHA:93400 | Congenital sialidosis type 2 | HP:0040283 - Occasional | | | 43 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | NPM1 CL E G H | 4869 | 7910 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 12 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | NPM1 CL E G H | 4869 | 7910 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 12 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | NUMA1 CL E G H | 4926 | 8059 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | NUMA1 CL E G H | 4926 | 8059 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | OCLN CL E G H | 100506658 | 8104 | OMIM:251290 | Band-Like calcification with simplified gyration and polymicrogyria | . | | | 23 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | P2RY12 CL E G H | 64805 | 18124 | OMIM:609821 | Bleeding disorder, platelet-type, 8 | . | | | 5 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | PEPD CL E G H | 5184 | 8840 | OMIM:170100 | Prolidase deficiency | | | | 66 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | PML CL E G H | 5371 | 9113 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 3 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | PML CL E G H | 5371 | 9113 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 3 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 58 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 58 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | PRF1 CL E G H | 5551 | 9360 | ORPHA:88 | Idiopathic aplastic anemia | HP:0040283 - Occasional | | | 58 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 134 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | PRKAR1A CL E G H | 5573 | 9388 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 134 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | RAB27A CL E G H | 5873 | 9766 | ORPHA:79477 | Griscelli syndrome type 2 | HP:0040283 - Occasional | | | 67 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | RARA CL E G H | 5914 | 9864 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 2 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | RARA CL E G H | 5914 | 9864 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 2 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | SAMD9 CL E G H | 54809 | 1348 | OMIM:617053 | Mirage syndrome | . | | | 8 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | SBDS CL E G H | 51119 | 19440 | ORPHA:88 | Idiopathic aplastic anemia | HP:0040283 - Occasional | | | 26 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | STAT3 CL E G H | 6774 | 11364 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 110 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | STAT3 CL E G H | 6774 | 11364 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 110 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | STAT5B CL E G H | 6777 | 11367 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 12 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | STAT5B CL E G H | 6777 | 11367 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 12 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 85 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 85 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 70 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 70 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | TBL1XR1 CL E G H | 79718 | 29529 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 22 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | TBL1XR1 CL E G H | 79718 | 29529 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 22 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | TBXA2R CL E G H | 6915 | 11608 | OMIM:614009 | BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13 | | | | 10 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | TERC CL E G H | 7012 | 11727 | ORPHA:88 | Idiopathic aplastic anemia | HP:0040283 - Occasional | | | 48 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | TERT CL E G H | 7015 | 11730 | ORPHA:88 | Idiopathic aplastic anemia | HP:0040283 - Occasional | | | 238 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | TET2 CL E G H | 54790 | 25941 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 3 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | TET2 CL E G H | 54790 | 25941 | ORPHA:824 | Primary myelofibrosis | HP:0040283 - Occasional | | | 3 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | TREX1 CL E G H | 11277 | 12269 | OMIM:225750 | Aicardi-Goutieres syndrome 1 | | | | 56 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 116 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040282 - Frequent | | | 116 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | USP18 CL E G H | 11274 | 12616 | OMIM:617397 | Pseudo-Torch syndrome 2 | . | | | 2 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | USP8 CL E G H | 9101 | 12631 | OMIM:219090 | Pituitary adenoma 4, ACTH-secreting, somatic | . | | | 7 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | WAS CL E G H | 7454 | 12731 | OMIM:313900 | Thrombocytopenia 1 | . | | | 65 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | WAS CL E G H | 7454 | 12731 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040282 - Frequent | | | 65 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | WAS CL E G H | 7454 | 12731 | OMIM:301000 | Wiskott-Aldrich syndrome | . | | | 65 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | WIPF1 CL E G H | 7456 | 12736 | ORPHA:906 | Wiskott-Aldrich syndrome | HP:0040282 - Frequent | | | 6 | | |
HP:0000979 | HP:0031364 | Ecchymosis | 2 | ZBTB16 CL E G H | 7704 | 12930 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 1 | | |
HP:0000979 | HP:0000967 | Petechiae | 2 | ZBTB16 CL E G H | 7704 | 12930 | ORPHA:520 | Acute promyelocytic leukemia | HP:0040282 - Frequent | | | 1 | | |